Comparative Study of Cidecin™ (Daptomycin) to Rocephin® (Ceftriaxone) in the Treatment of Moderate to Severe Community-Acquired Acute Bacterial Pneumonia
NCT00538694 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL
Last updated 2019-11-14
Summary
To evaluate the safety and efficacy of daptomycin in adults who have pneumonia due to Streptococcus pneumoniae.
Conditions
- Pneumonia, Bacterial
Interventions
- DRUG
-
daptomycin
Sponsors & Collaborators
-
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2000-10-31
- Primary Completion
- 2001-09-30
- Completion
- 2001-09-30
More Related Trials
-
Daptomycin in the Treatment of Catheter-Related Staphylococcus Aureus
NCT00507247 ·Status: COMPLETED ·Phase: PHASE2
-
Daptomycin in the Treatment of Subjects With Infective Endocarditis or Bacteremia Due to S. Aureus
NCT00093067 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Ceftaroline Fosamil Versus a Comparator in Adult Subjects With Community-acquired Bacterial Pneumonia (CABP) With Risk for Methicillin-resistant Staphylococcus Aureus
NCT01645735 ·Status: COMPLETED ·Phase: PHASE4
-
Safety, Tolerability, Efficacy and Pharmacodynamics of CAL02 in Severe Pneumonia Caused by Streptococcus Pneumoniae
NCT02583373 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of Daptomycin Versus Vancomycin or Teicoplanin for Treatment of Complicated Skin and Soft Tissue Infections
NCT00430937 ·Status: TERMINATED ·Phase: PHASE3
-
Ceftobiprole in the Treatment of Patients With Community-Acquired Pneumonia
NCT00326287 ·Status: COMPLETED ·Phase: PHASE3
-
Daptomycin in the Treatment of Patients With Renal Insufficiency and Complicated Skin and Skin Structure Infections
NCT00102947 ·Status: TERMINATED ·Phase: PHASE4
-
Phase 4 Efficacy and Safety Study of Cubicin® With and Without Combination Therapy in S. Aureus Infective Endocarditis (SAIE)
NCT00638157 ·Status: TERMINATED ·Phase: PHASE4
-
Safety and Efficacy Study of CUBICIN (Daptomycin) Under Conditions of Actual Use
NCT01219114 ·Status: WITHDRAWN
-
Daptomycin Versus Vancomycin in Participants With Skin Infections Due to MRSA
NCT01419184 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Single Dose Daptomycin in Pediatric Patients With Gram-positive Infection for Which They Are Receiving Standard Antibiotics
NCT00136292 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of Daptomycin for the Emergency Department Treatment of Complicated Skin and Skin Structure Infections
NCT01549613 ·Status: COMPLETED ·Phase: PHASE4
-
Vancomycin Versus Ceftaroline in Patients With Infections Caused by MRSA That Are Susceptible to Ceftaroline
NCT01724671 ·Status: UNKNOWN
-
IL-10 Stratifying Tool for Towards Antibiotic Selection for MRSaB
NCT02660346 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Study of Cefiderocol (S-649266) for the Treatment of Nosocomial Pneumonia Caused by Gram-negative Pathogens
NCT03032380 ·Status: COMPLETED ·Phase: PHASE3
-
Safety & Efficacy of Daptomycin Versus Standard of Care (SOC) in 1 - 17 Year Olds With Staphylococcus Aureus Bacteremia (MK-3009-005)
NCT01728376 ·Status: COMPLETED ·Phase: PHASE4
-
Cefepime vs. Ceftriaxone to Treat Nursing Home-Acquired Pneumonia
NCT00358202 ·Status: COMPLETED ·Phase: PHASE4
-
Ceftobiprole in the Treatment of Patients With Staphylococcus Aureus Bacteremia
NCT03138733 ·Status: COMPLETED ·Phase: PHASE3
-
Ceftobiprole in the Treatment of Resistant Staphylococcus Aureus Skin and Skin Structure Infections
NCT00210899 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Nephrotoxicity and Hospital Costs in Patients With Methicillin-Resistant Staphylococcus Aureus Bacteremia Who Received Vancomycin Versus Teicoplanin Therapy
NCT01352936 ·Status: UNKNOWN
-
China Registration Study in Patients With Skin Infections
NCT00772447 ·Status: COMPLETED ·Phase: PHASE3
-
Daptomycin for the Treatment of Infections Due to Gram-Positive Bacteria
NCT00055198 ·Status: TERMINATED ·Phase: PHASE3
-
Cefiderocol and Ampicillin-sulbactam vs. Colistin +/- Meropenem for Carbapenem Resistant A. Baumannii
NCT05922124 ·Status: RECRUITING ·Phase: PHASE4
-
Pharmacokinetics (PK) and Safety Evaluation of Daptomycin in Children Ages 3-24 Months With Proven or Suspected Gram-positive Infections or Peri-Operative Subjects Receiving Prophylactic Antibiotics
NCT01019395 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Efficacy and Safety of Intravenous Cefiderocol (S-649266) Versus Imipenem/Cilastatin in Complicated Urinary Tract Infections
NCT02321800 ·Status: COMPLETED ·Phase: PHASE2